Violation Detail
Standard Cited: 19101030 C01 IV B Bloodborne pathogens.
Inspection Nr: 1194099.015
Citation: 01001A
Citation Type: Serious
Abatement Date: 05/04/2017 2
Initial Penalty: $5,975.00
Current Penalty: $4,122.00
Issuance Date: 04/10/2017
Nr Instances: 3
Nr Exposed: 44
Related Event Code (REC):
Gravity: 1
Report ID: 0524200
Contest Date:
Final Order: 05/04/2017
Emphasis:
Type | Latest Event | Event Date | Penalty | Abatement Due Date | Citation Type | Failure to Abate Inspection |
---|---|---|---|---|---|---|
Penalty | I: Informal Settlement | 05/04/2017 | $4,122.00 | 05/04/2017 | Serious | |
Penalty | Z: Issued | 04/10/2017 | $5,975.00 | 05/04/2017 | Serious |
Text For Citation: 01 Item/Group: 001A Hazard:
29 CFR 1910.1030(c)(1)(iv)(B): The review and update of the exposure control plan did not document annually consideration and implementation of appropriate commercially available and effective safer medical devices designed to eliminate or minimize occupational exposure: a) Octapharma Plasma, Inc., Northlake, IL- On November 28, 2016, the employer did not document in the Exposure Control Plan the annual consideration and implementation of appropriate commercially available and effective safer medical devices designed to eliminate or minimize occupational exposure. In accordance with 29 CFR 1903.19(d), abatement certification is required for this violation (using the CERTIFICATION OF CORRECTIVE ACTION WORKSHEET), and in addition, documentation demonstrating that abatement is complete must be included with your certification. This documentation may include, but is not limited to, evidence of the purchase or repair of the equipment, photographic or video evidence of abatement, or other written records.